Format

Send to

Choose Destination
Int J Dev Biol. 2013;57(2-4):133-9. doi: 10.1387/ijdb.130031nv.

Classification, epidemiology and therapies for testicular germ cell tumours.

Author information

1
Department of Urology, Freeman Hospital, Newcastle upon Tyne, United Kingdom. nikhilvasdev@doctors.org.uk

Abstract

Testicular germ cell tumours (TGCT) account for between 1% and 1.5% of male neoplasms and 5% of urological tumours in general. They are classified broadly into Seminoma, which resemble primordial germ cells (PGCs), and Non-Seminoma, which are either undifferentiated (embryonal carcinoma) or differentiated (exhibiting a degree of embryonic (teratoma) or extra-embryonic (yolk sac choriocarcinoma) patterning). We present the current details of the latest classification, epidemiology and treatment aspects of TGCT in the UK in our review.

PMID:
23784823
DOI:
10.1387/ijdb.130031nv
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for The International Journal of Developmental Biology
Loading ...
Support Center